Lowered levels of serum albumin and HDL‐cholesterol in children with a recent mild infection

References

• Pesonen E., Liuba P. Footprints of atherosclerotic coronary heart disease in children. Rev Port Cardiol 2004; 23: 127–31
   Google Scholar
• Libby P., Egan D., Skarlatos S. Role of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and need for future research. Circulation 1997; 96: 4095–103
   PubMed Web of Science ®Google Scholar
• Zhu J., Quyyumi A. A., Norman J. E., Csako G., Waclawiw M. A., Shearer G. M. Effects of total pathogen burden on coronary artery disease risk and C‐reactive protein levels. Am J Cardiol 2000; 85: 140–6
   PubMed Web of Science ®Google Scholar
• Kovanen P. T. Atheroma formation: defective control in the intimal round‐trip of cholesterol. Eur Heart J 1990; 11((Suppl E))238–46
   Google Scholar
• Sammalkorpi K., Valtonen V., Kerttula Y., Nikkilä E., Taskinen M‐R. Changes in serum lipoprotein pattern induced by acute infections. Metabolism 1988; 119: 557–61
   Google Scholar
• Djousse L., Rothman K. J., Cupples L. A., Levy D., Ellison R C. Serum albumin and risk of myocardial infarction and all cause mortality in the Framingham offspring study. Circulation 2002; 106: 2919–24
   PubMed Web of Science ®Google Scholar
• Gabay C., Kushner I. Acute–phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340: 448–54
   PubMed Web of Science ®Google Scholar
• Zoellner H., Hofler M., Beckman R., Hufnagl P., Vanyek E., Wojta J., et al. Serum albumin is a specific inhibitor of apoptosis in human endothelial cells. J Cell Sci 1996; 109: 2571–80
   PubMed Web of Science ®Google Scholar
• Belayev L., Zhao W., Pattany P. M., Weaver R. G., Huh P. W., Lin B., et al. Diffusion weighted magnetic resonance imaging confirms marked neuroprotective efficacy of albumin therapy in focal cerebral ischemia. Stroke 1998; 29: 2587–99
   PubMed Web of Science ®Google Scholar
• Kuller L. H., Eicner J. E., Orcard T. J., Grandits G. A., McCallum, Tracy R. P. The relation between serum albumin levels and risk of coronary heart disease in the multiple risk factor intervention trial. Am J Epidemiol 1991; 134: 1266–77
   PubMed Web of Science ®Google Scholar
• Honkanen V. E., McCrindle B. W., Laxer R. M., Feldman B. M., Schneider R., Silverman E. D. Clinical relevance of the risk factors for coronary artery inflammation in Kawasaki disease. Pediatr Cardiol 2003; 24: 122–6
   PubMed Web of Science ®Google Scholar
• Viikari J., Rönnemaa T., Seppänen A., Marniemi J., Porkka K., Räsänen L., et al. Serum lipids and lipoproteins in children, adolescents and young adults in. 1980–1986. Ann Med 1991; 23: 53–9
   PubMed Web of Science ®Google Scholar
• Siegel J., Schlumberger H., Klose S., Ziegenhorn J., Wahlefeld A. W. Improved reagent for the enzymatic determination of serum cholesterol. J Clin Chem Clin Biochem 1981; 19: 838–9
   Google Scholar
• Kostner G. M. Enzymatic determination of cholesterol in high density lipoprotein fractions prepared by polyanion precipitation. Clin Chem 1976; 22: 695
   PubMed Web of Science ®Google Scholar
• Friedewald W. T., Levy R., Fredrickson D. S. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of preparative ultracentrifuge. Clin Chem 1972; 18: 499–502
   PubMed Web of Science ®Google Scholar
• Dati F., Schumann G., Thomas L., Aguzzi F., Baudner S., Bienvenu J., et al. Consensus of a group of professional societies and diagnostic companies on guidelines for interim reference ranges for 14 proteins in serum based on the standardization against the IFCC/BCR/CAP Reference material (CRM 470). International federation of Clinical Chemistry. Community Bureau of Reference of the Commission of the European Communities. College of American Pathologists. Eur J Clin Chem Clin Biochem 1996; 34: 517–20
   PubMedGoogle Scholar
• SAS/STAT User's Guide. SAS Institute Inc, Cary NC 1998
   Google Scholar
• Pesonen E., Rapola J., Viikari J., Turtinen J., Åkerblom H. K. Altered serum lipid profile after systemic infection in children: risk factor for CHD?. Eur Heart J 1993; 14((Suppl K))7–11
   Google Scholar
• Ross R., Glomset J. A. The pathogenesis of atherosclerosis. N Engl J Med 1976; 295: 369–77 and 420–5
   PubMed Web of Science ®Google Scholar
• Korppi M. Non‐specific host response markers in the differentiation between pneumococcal and viral pneumonia: What is the most accurate combination?. Pediatr Int 2004; 46: 545–50
   PubMed Web of Science ®Google Scholar
• Feingold K. R., Grunfeld C. Role of cytokines in inducing hyperlipidemia. Diabetes 1992; 41((Suppl 2))97–101
   PubMed Web of Science ®Google Scholar
• Khovidhunkit W., Memon R. A., Feingold K. R., Grunfeld C. Infection and inflammation‐induced proatherogenic changes of lipoproteins. J Infect Dis 2000; 181((Suppl 3))462–72
   PubMedGoogle Scholar
• Van Lenten B. J., Wagner A. C., Nayak D. P., Hama S., Navab M., Fogelman A. M. High‐density lipoprotein loses its anti‐inflammatory properties during acute influenza A infection. Circulation 2001; 103: 2283–8
   PubMed Web of Science ®Google Scholar
• Liuba P., Persson J., Luoma J., Ylä‐Herttuala S., Pesonen E. Acute infections in children are accompanied by oxidative modification of LDL and decrease of HDL cholesterol, and are followed by thickening of carotid intima‐media. Eur Heart J 2003; 24: 515–21
   PubMed Web of Science ®Google Scholar
• Laaksonen R., Janatuinen T., Vesalainen R., Lehtimäki T., Elovaara I., Jaakkola O., et al. High oxidized LDL and elevated plasma homocysteine contribute to the early reduction of myocardial flow reserve in healthy adults. Eur J Clin Invest 2002; 32: 795–802
   Google Scholar
• Zhang W. J., Frei B. Albumin selectively inhibits TNFalpha–induced expression of vascular cell adhesion molecule–1 in human aortic endothelial cells. Cardiovasc Res 2002; 55: 820–9
   PubMed Web of Science ®Google Scholar
• Shimamoto T. The relationship of edematous reaction in arteries to atherosclerosis and thrombosis. J Atheroscler Res 1963; 3: 87–102
   Google Scholar
• Reuben D. B., Ferrucci L., Wallace R., Tracy R. B., Corti M. C., Heimovitz H., et al. The prognostic value of serum albumin in healthy older persons with low and high serum interleukin–6 (IL–6) levels. J Am Geriatr Soc 2000; 48: 1404–7
   PubMed Web of Science ®Google Scholar
• Djousse L., Rothman K. J., Cupples L. A., Levy D., Ellison C. Effects of serum Albumin and Bilirubin on the Risk of Myocardial Infarction (the Framingham Offspring Study). Am J Cardiol 2003; 91: 485–8
   PubMed Web of Science ®Google Scholar